Recent pharmaceutical cases in regulatory and intellectual property law have resulted in developments on several fronts, including:

  • regulatory matters;
  • patent validity and damages;
  • Patented Medicines (Notice of Compliance) Regulations proceedings; and
  • class actions.

In this paper, we review some of the most notable Canadian decisions from 2015 that will continue to impact the legal landscape for the pharmaceutical industry in Canada over the coming year.

Download the brochure here: 2015 Pharma in Brief (pdf 2.15MB)



Practice area:

Industry:

Recent publications

Futurist Blockchain Conference | Norton Rose Fulbright

Publication

Patenting blockchain innovations

The following are practical tips from over nine years of experience successfully obtaining blockchain patent grants from dozens of patent offices around the world.

Canada | May 14, 2025

Patents
Financial-investors-Financial-rising-graph-and-chart-with-lines-and-numbers

Publication

CSA takes steps to encourage Canadian IPOs and subsequent financings

On April 17, 2025, the CSA published harmonized blanket orders that provide exemptions from certain prospectus and disclosure requirements relating to public offerings (the blanket orders).

Canada | May 14, 2025

Corporate, M&A and securities
wide angle abstract background view of steel light

Publication

Securities regulators amend investment limits for offering memorandum exemption

Canadian securities regulators have made changes to give investors greater access to exempt markets.

Canada | May 12, 2025

Capital markets
Site search

Subscribe and stay up to date with the latest legal news, information and events . . .

Subscribe now